TEDMED | What if we can detect diseases so early that we can avoid them altogether? @TEDMED | Uploaded April 2018 | Updated October 2024, 10 hours ago.
The team at Freenome, lead by CEO and Co-founder Gabriel Otte, is working to change the way we approach diagnosis. Instead of waiting until patients are symptomatic, they have developed blood-based screenings for a range of diseases, including cancer. Tune in to Gabriel’s 2017 TEDMED Hive Talk to learn how the company is working to help patients when they’re asymptomatic and giving them the highest chance of being cured.
The team at Freenome, lead by CEO and Co-founder Gabriel Otte, is working to change the way we approach diagnosis. Instead of waiting until patients are symptomatic, they have developed blood-based screenings for a range of diseases, including cancer. Tune in to Gabriel’s 2017 TEDMED Hive Talk to learn how the company is working to help patients when they’re asymptomatic and giving them the highest chance of being cured.